All lobbying filings

KELLEY DRYE & WARREN LLP

Lobbying for TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Development of federal public policy and advocacy strategy and lobbying federal government

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 9

HR 2586
Reentry Act of 2025
S 1720
Due Process Continuity of Care Act
HR 1510
Due Process Continuity of Care Act
S 1329
PEER Support Act
HR 2741
PEER Support Act
S 3522
No Red Tape For Addiction Treatment Act
S 3812
WORK to Save Lives Act
HR 7479
WORK to Save Lives Act
HR 7148
Consolidated Appropriations Act, 2026

Lobbying activity 1

Health Issues

Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.